American Healthcare REIT, Inc.

NYSE:AHR Stock Report

Market Cap: US$10.5b

American Healthcare REIT Future Growth

Future criteria checks 4/6

American Healthcare REIT is forecast to grow earnings and revenue by 25.2% and 12.7% per annum respectively. EPS is expected to grow by 22.7% per annum. Return on equity is forecast to be 5% in 3 years.

Key information

25.2%

Earnings growth rate

22.66%

EPS growth rate

Health Care REITs earnings growth23.7%
Revenue growth rate12.7%
Future return on equity5.03%
Analyst coverage

Good

Last updated22 Jun 2026

Recent future growth updates

Recent updates

Narrative Update • Jun 18

AHR: Equity Offering And Strong Q1 Performance Will Support Future Returns

Analysts have kept their fair value estimate for American Healthcare REIT steady at about $58.85 per share, while modestly adjusting assumptions around the discount rate, revenue growth, profit margin, and future P/E to reflect updated views on the company’s long term financial profile. What’s in the News for American Healthcare REIT American Healthcare REIT priced an underwritten public offering of 14,000,000 common shares at about US$50.005 per share, with expected gross proceeds of roughly US$705.6m before expenses, and a 30 day option for underwriters to buy an additional 2,100,000 shares.
Narrative Update • Jun 03

AHR: Equity Offering And Lower Impairments Will Support Future Earnings

Narrative Update on American Healthcare REIT The analyst price target for American Healthcare REIT has shifted modestly to about $58.85 from roughly $58.08, with analysts pointing to small adjustments in the discount rate, profit margin expectations, and future P/E assumptions to support the new view. What’s in the News American Healthcare REIT priced an underwritten public offering of 14,000,000 common shares, expected to generate approximately US$705.6 million in gross proceeds, with BofA Securities as underwriter and a 30 day option to purchase an additional 2,100,000 shares.
Seeking Alpha • May 19

American Healthcare REIT Is Capitalizing On Extremely Favorable Fundamentals

Summary American Healthcare REIT is positioned to benefit from a multi-year supply-demand imbalance in senior housing, supporting robust occupancy and rent growth. AHR's double-digit NFFO and SPNOI growth, combined with a healthy acquisition pipeline and declining leverage, underpin expectations for mid-teens total returns. Trading at ~24x 2026 NFFO, AHR is a value play among senior housing REITs, with a well-covered 2% dividend yield and strong organic and external growth prospects. The primary risk is AHR's reliance on a high equity multiple for external growth, but strong fundamentals and favorable demographics support continued outperformance. Read the full article on Seeking Alpha
Narrative Update • May 16

AHR: Improved Impairment Profile And Equity Access Will Support Earnings Outlook

Analysts have inched their price target on American Healthcare REIT up to about $58. This reflects updated views on slightly higher profit margins, a revised discount rate, and adjusted expectations for revenue growth and future P/E.
Narrative Update • Apr 24

AHR: Expanded Equity Access Will Support Earnings Outlook Through Leadership Change

Analysts have made a slight trim to their price target on American Healthcare REIT to $57.92 from $58.08, linking the update to revised assumptions for higher revenue growth, a more modest profit margin, and a similar forward P/E outlook. What's in the News Filed a follow-on equity offering of up to US$1.75 billion in common stock as an at-the-market program, signaling potential ongoing access to equity capital (Key Developments).
Narrative Update • Apr 10

AHR: Expanded Equity Access Will Support Earnings Outlook Through Leadership Change

Analysts have reaffirmed their price target on American Healthcare REIT at $58.08 per share, citing largely unchanged fair value, growth, margin and P/E assumptions, with only minor tweaks to the discount rate and long term inputs. What's in the News Filed a follow on equity offering for up to US$1.75b of common stock through an at the market program, giving the company additional access to equity capital if it chooses to issue shares (Key Developments).
Narrative Update • Mar 26

AHR: Expanded Equity Program Will Support Earnings Outlook Despite Leadership Transition

Analysts have nudged their price target for American Healthcare REIT slightly higher to about $58.08 from roughly $57.62, reflecting updated assumptions that include a modestly different revenue growth outlook, a higher projected profit margin, and a slightly lower future P/E multiple. What's in the News American Healthcare REIT completed a follow on equity offering totaling about $769.9m across multiple tranches of common stock, including offerings of 2,455,858 shares at $40.96, 5,866,000 shares at $42.61, 659,504 shares at $49.22, and 6,611,272 shares at $48.16, conducted as an at the market program (Key Developments).
Narrative Update • Mar 11

AHR: Equity Offerings And Leadership Shift Will Shape Balanced Forward Outlook

Analysts have raised their price target on American Healthcare REIT by about $1.54 to reflect updated assumptions around fair value, discount rate, revenue growth, profit margin and expected future P/E. What's in the News American Healthcare REIT completed a follow on equity offering totaling about $769.9m across multiple tranches of common stock, including 2,455,858 shares at $40.96, 5,866,000 shares at $42.61, 659,504 shares at $49.217375, and 6,611,272 shares at $48.162553 in an at the market structure (Key Developments).
Narrative Update • Feb 25

AHR: Leadership Transition And Stable Assumptions Will Shape Forward Opportunity

Analysts have kept their price target for American Healthcare REIT effectively unchanged at about $56.08 per share, reflecting only minor adjustments to their discount rate, revenue growth, profit margin, and forward P/E assumptions. What's in the News American Healthcare REIT, Inc.
Narrative Update • Feb 10

AHR: Follow-On Equity Offering Will Support 2025 Guidance And Future Upside

Analysts have nudged their price target on American Healthcare REIT slightly higher to about US$56.08 from roughly US$56, citing modest adjustments to discount rate, revenue growth and profit margin assumptions, while keeping the forward P/E view broadly unchanged. What's in the News CEO and President Danny Prosky has taken a medical leave of absence effective February 3, 2026, following a recent medical event.
Narrative Update • Jan 27

AHR: Follow-On Offering Will Support 2025 Guidance And Future Upside

Analysts have trimmed their price target on American Healthcare REIT slightly to about US$56, reflecting updated assumptions around discount rates, revenue growth, profit margins, and a lower future P/E multiple. What's in the News American Healthcare REIT filed a follow-on equity offering of 8,100,000 common shares of its common stock.
Narrative Update • Jan 11

AHR: Follow-On Equity Offering Will Support Raised Guidance And Future Upside

Analysts have kept their fair value estimate for American Healthcare REIT steady at US$56.08 per share, citing relatively unchanged assumptions for revenue growth, profit margin and future P/E, along with a slightly adjusted discount rate. What's in the News Completed a follow-on equity offering of 8,100,000 common shares at US$47.75 per share, raising about US$386.775 million (Follow on Equity Offerings) Filed follow-on equity offering documents for 8,100,000 common shares of American Healthcare REIT, Inc.
Narrative Update • Dec 24

AHR: Follow-On Equity Offering And Raised Guidance Will Drive Future Upside

Analysts have modestly raised their price target on American Healthcare REIT by approximately 0.1 percent to about $56.08. This reflects slightly improved views on discount rates and long term profit margins, while leaving their fair value estimate effectively unchanged.
Narrative Update • Dec 10

AHR: Follow-On Equity Offering Will Support Future Upside Potential

Analysts have slightly lowered their price target on American Healthcare REIT to approximately $56.08 per share from about $56.08 per share, reflecting marginally reduced discount rate and future P/E assumptions while maintaining largely unchanged growth and profitability expectations. What's in the News Completed a follow on equity offering of 8,100,000 common shares at $47.75 per share, raising approximately $386.8 million, with the securities structured as an income trust (Key Developments) Filed a follow on equity offering for 8,100,000 shares of common stock, signaling plans to access additional equity capital (Key Developments) Recorded consolidated impairment charges of $3.8 million on real estate investments for the quarter ended September 30, 2025, reflecting write downs on certain properties (Key Developments) Raised full year 2025 guidance, increasing expected diluted EPS to $0.47 to $0.50, same store NOI growth to 13.0 to 15.0 percent, and net income attributable to common stockholders to $78 million to $83 million (Key Developments) Valuation Changes Fair Value Estimate remains unchanged at approximately $56.08 per share, indicating no revision to the intrinsic value assessment.
Narrative Update • Nov 26

AHR: Upcoming Equity Offerings And Raised Guidance Will Drive Momentum

Analysts have raised their price target for American Healthcare REIT from $48.73 to $56.08. They cite a significantly improved revenue growth outlook, even though profit margin projections have been reduced.
Narrative Update • Nov 12

AHR: Improved Profit Margins And Lower Discount Rate Will Support Outlook

Analysts have raised their price target for American Healthcare REIT from $46.92 to $48.73. They cite improved profit margins and a lower discount rate as key factors behind the positive revision.
Narrative Update • Oct 28

Outlook Will Strengthen As Capital Access And Deal Pipeline Expand

Analysts have slightly increased their price target for American Healthcare REIT, raising it from $46.75 to $46.92. Minor adjustments in key financial assumptions suggest a modestly improved outlook for the company.
Narrative Update • Oct 14

Low Supply And Value-Based Care Will Drive Senior Markets

Analysts have raised their price target for American Healthcare REIT from $46.00 to $46.75, citing slight improvements in profit margin forecasts and a marginally higher fair value projection. What's in the News American Healthcare REIT, Inc.
Narrative Update • Aug 27

Low Supply And Value-Based Care Will Drive Senior Markets

Despite a notable decline in net profit margin and a sharp increase in future P/E, analysts have raised their fair value target for American Healthcare REIT from $42.45 to $45.27. What's in the News Management reports strong organic earnings growth and a robust pipeline, with over $300 million in awarded deals, focusing acquisitions on high-quality long-term care assets under the RIDEA structure.
User avatar
New Narrative • Jul 16

Senior Care Demand And Capital Recycling Will Empower Future Markets

Rising demand for senior care and strategic asset recycling are driving sustained revenue, margin, and earnings growth, supported by favorable demographic trends and limited new supply.
Seeking Alpha • Mar 25

American Healthcare REIT Has Growth Potential But Is A Hold Due To Valuation

Summary American Healthcare REIT is a diversified REIT focusing on senior care properties, showing strong growth and benefiting from the aging population trend. AHR's recent performance includes an 8.5% same-store growth and a 21.6% increase in Net Operating Income in Q4 2024. Valuation using the dividend discount model suggests a $30.00 share value, indicating a 0.54% upside, leading to a "hold" recommendation. Risks include high debt and potential interest rate increases, impacting expansion costs and overall profitability. Read the full article on Seeking Alpha

Earnings and Revenue Growth Forecasts

NYSE:AHR - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20283,390230N/A4942
12/31/20273,020175N/A4357
12/31/20262,720112N/A3857
3/31/20262,371100315315N/A
12/31/20252,25870294294N/A
9/30/20252,19427281299N/A
6/30/20252,142-33245255N/A
3/31/20252,104-41243243N/A
12/31/20242,064-38176176N/A
9/30/20242,005-33154142N/A
6/30/20241,946-35122108N/A
3/31/20241,904-499069N/A
12/31/20231,865-719999N/A
9/30/20231,825-9284107N/A
6/30/20231,782-99119135N/A
3/31/20231,699-104149149N/A
12/31/20221,619-81148148N/A
9/30/20221,529-5763133N/A
6/30/20221,427-49170N/A
3/31/20221,355-39-2646N/A
12/31/20211,264-481818N/A
9/30/20211,971-95188N/A
6/30/20211,694-9-3674N/A
3/31/20211,147068188N/A
12/31/20201,185291219N/A
9/30/2020433-52256N/A
6/30/2020694-1893212N/A
3/31/20201,240-205118N/A
12/31/20191,221-5N/A117N/A
9/30/20191,199-12N/A122N/A
6/30/20191,1819N/A114N/A
3/31/20191,15511N/A106N/A
12/31/20181,13113N/A107N/A
9/30/20181,11418N/A116N/A
6/30/20181,09219N/A124N/A
3/31/20181,07123N/A131N/A
12/31/20171,04911N/A128N/A
9/30/20171,023-25N/A110N/A
6/30/20171,008-73N/A92N/A
3/31/2017990-115N/A78N/A
12/31/2016980-146N/A114N/A
9/30/2016832-181N/A72N/A
6/30/2016615-154N/A57N/A
3/31/2016393-128N/A38N/A
12/31/2015160-101N/A-23N/A
9/30/201563-43N/A-7N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: AHR's forecast earnings growth (25.2% per year) is above the savings rate (3.5%).

Earnings vs Market: AHR's earnings (25.2% per year) are forecast to grow faster than the US market (18.4% per year).

High Growth Earnings: AHR's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: AHR's revenue (12.7% per year) is forecast to grow faster than the US market (12.7% per year).

High Growth Revenue: AHR's revenue (12.7% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: AHR's Return on Equity is forecast to be low in 3 years time (5%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/07 16:00
End of Day Share Price 2026/07/07 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

American Healthcare REIT, Inc. is covered by 18 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Anthony PowellBarclays
Richard HightowerBarclays
Juan SanabriaBMO Capital Markets Equity Research